The E288K colon tumor variant of DNA polymerase β is a sequence specific mutator.
DNA polymerase β (pol β) is the main polymerase involved in base excision repair (BER), which is a pathway responsible for the repair of tens of thousands of DNA lesions per cell per day. Our recent efforts in sequencing colon tumors showed that 40% of the tumors sequenced possessed a variant in the coding region of the POLB gene; one of these variants is E288K. Expression of the E288K variant in cells leads to an increase in the frequency of mutations at AT base pairs. In vitro, the E288K variant is as active as and binds one-base-gapped DNA with the same affinity as wild-type pol β. Single-turnover kinetic data for the E288K variant show that its mutator phenotype is specific for misincorporating opposite template A up to 6-fold more than the wild-type enzyme and that this is due to a decrease in the degree of discrimination in nucleotide binding. Molecular modeling suggests that the substitution of Lys at position 288 causes the polymerase to adopt a more open conformation, which may be disrupting the nucleotide binding pocket. This may explain the reduced degree of discrimination at the level of nucleotide binding. The enhanced mutagenesis of the E288K variant could lead to genomic instability and ultimately a malignant tumor phenotype.
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Drew L
DL
Murphy
Katherine A
KA
Donigan
Joachim
J
Jaeger
Joann B
JB
Sweasy
D002460:Cell Line; D002942:Circular Dichroism; D003110:Colonic Neoplasms / Q000201:enzymology* / Q000235:genetics*; D019951:DNA Polymerase beta / Q000235:genetics* / Q000378:metabolism; D042822:Genomic Instability / Q000235:genetics; D006801:Humans; D016296:Mutagenesis / Q000235:genetics; D009154:Mutation
D019951:DNA Polymerase beta